ReviewDer Orthopade2007
[Modern treatment of ankylosing spondylitis].
Review in Der Orthopade, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 16 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bechterew's disease belongs to subgroup of spondyloarthritis. Even today there is still a delay of 5-10 years between the first occurrence of symptoms and the final diagnosis of ankylosing spondylitis. Without treatment the spine increasingly stiffens and the peripheral (mostly large) joints are often destroyed by inflammatory processes. Ankyloses of the joints between vertebrae and ribs may cause stiffness of the thorax. As the complaints most often start within the third decade of life and show a chronic progressive course, even young adults often have to deal with a considerable impairment due to pain and stiffness. Thus, early diagnosis is of utmost importance as today treatment with novel drugs is feasible and the TNFalpha inhibitors are particularly effective during the early stages of the disease. All conservative orthopedic measures are used concomitantly. Surgery encompasses the early resection of inflamed mucosa in joints. In later stages of the disease reconstructive methods, i.e. prosthetics are often applied. Spondylodesis to erect the body, necessary in the end stage of the disease, is beneficial, but elaborate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.